V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006554 | 220002525 | 0 | 35.3 | Curative (C) | 2015-11-12 | 2015-11-18 | AML Downs | N | N | 220030539 | NOT MATCHED |
| 220006555 | 220002525 | 1.75 | 116.6 | Curative (C) | 2015-07-31 | 2015-08-01 | AML 19 TRIAL | 01 | N | 220030539 | AML19 TRIAL |
| 220006556 | 220002525 | 1.68 | 72.3 | Curative (C) | null | 2016-12-27 | AML 19 TRIAL | Y | N | 220030539 | AML19 TRIAL |
| 220006557 | 220002526 | null | null | Palliative (P) | 2017-01-09 | 2017-01-10 | Nilotinib | N | N | 220030543 | NILOTINIB |
| 220006558 | 220002527 | 1.6 | 85.4 | Palliative (P) | 2014-01-07 | 2014-01-08 | FLAG + Idarubicin | N | N | 220030548 | FLAG + IDARUBICIN |
| 220006559 | 220002527 | null | null | Curative (C) | 2015-05-08 | 2015-05-30 | Nilotinib | N | N | 220030548 | NILOTINIB |
| 220006560 | 220002528 | 1.58 | null | Curative (C) | 2015-02-03 | 2015-02-04 | FLAG + Idarubicin | N | N | 220030551 | FLAG + IDARUBICIN |
| 220006561 | 220002528 | 1.73 | 116.6 | Curative (C) | 2013-02-27 | 2013-02-27 | AML 19 TRIAL | 01 | N | 220030551 | AML19 TRIAL |
| 220006562 | 220002529 | 1.75 | 58.5 | Curative (C) | 2017-03-24 | 2017-03-24 | FLAG + Idarubicin | N | N | 220030553 | FLAG + IDARUBICIN |
| 220006563 | 220002529 | 0 | null | Curative (C) | 2014-12-17 | 2014-12-17 | Nilotinib | 2 | N | 220030553 | NILOTINIB |
| 220006564 | 220002529 | 1.49 | 120 | Disease modification (D) | 2015-08-29 | 2015-08-29 | Nilotinib | N | N | 220030553 | NILOTINIB |
| 220006565 | 220002529 | 1.66 | 52.2 | Curative (C) | 2014-08-19 | 2014-08-20 | AML 19 TRIAL | Y | N | 220030553 | AML19 TRIAL |
| 220006566 | 220002529 | 1.85 | 95.8 | Curative (C) | 2017-03-24 | 2017-03-26 | AML 19 TRIAL | Y | null | 220030553 | AML19 TRIAL |
| 220006567 | 220002529 | 0 | null | Curative (C) | 2013-09-16 | 2013-09-17 | Nilotinib | N | N | 220030553 | NILOTINIB |
| 220006568 | 220002529 | 1.51 | null | Disease modification (D) | null | 2017-06-05 | ALL Ph+ve Dasatinib - Das alone | N | N | 220030553 | NOT MATCHED |
| 220006569 | 220002530 | null | 72.5 | Curative (C) | 2014-11-18 | 2015-07-16 | Nilotinib | 2 | N | 220030568 | NILOTINIB |
| 220006570 | 220002531 | 0 | 70 | Curative (C) | 2014-12-31 | 2014-12-31 | AML Interim Guidelines | N | N | 220030570 | NOT MATCHED |
| 220006571 | 220002531 | 1.77 | 76.8 | Curative (C) | 2014-11-27 | 2014-12-03 | AML 19 TRIAL | 01 | N | 220030570 | AML19 TRIAL |
| 220006572 | 220016161 | 1.68 | 86.7 | null | 2015-12-08 | 2015-12-09 | FLAG + Idarubicin | N | N | 220030573 | FLAG + IDARUBICIN |
| 220006573 | 220016161 | 1.62 | 0 | Curative (C) | 2013-08-20 | 2013-08-20 | null | N | N | 220030573 | NOT MATCHED |
| 220006574 | 220016161 | 1.66 | 73.5 | Curative (C) | 2014-01-03 | 2014-01-05 | AML 19 TRIAL | N | N | 220030573 | AML19 TRIAL |
| 220006575 | 220016161 | 1.75 | 72 | Curative (C) | 2013-09-21 | 2013-09-21 | AML 19 TRIAL | 01 | N | 220030573 | AML19 TRIAL |
| 220006576 | 220002532 | 1.66 | 87.2 | Curative (C) | 2015-08-06 | 2015-08-06 | AML 19 TRIAL | 01 | N | 220030586 | AML19 TRIAL |
| 220006577 | 220002532 | 1.62 | 82 | Curative (C) | 2013-07-22 | 2013-07-22 | AML 19 TRIAL | 01 | N | 220030586 | AML19 TRIAL |
| 220006578 | 220002532 | 1.66 | 60.3 | Curative (C) | 2017-05-12 | 2017-05-12 | AML 19 TRIAL | Y | N | 220030586 | AML19 TRIAL |
| 220006579 | 220002532 | 1.61 | null | Curative (C) | null | 2014-01-22 | FLAG + Idarubicin | 2 | N | 220030586 | FLAG + IDARUBICIN |
| 220006580 | 220002532 | 0 | 38.1 | Curative (C) | 2014-12-18 | 2014-12-18 | null | 02 | N | 220030586 | NOT MATCHED |
| 220006581 | 220021255 | 0 | 78.3 | Adjuvant (A) | 2013-03-03 | 2013-03-04 | Nilotinib | N | N | 220030593 | NILOTINIB |
| 220006582 | 220002533 | 0 | 0 | Disease modification (D) | 2013-10-08 | 2013-10-08 | Nilotinib | 02 | N | 220030594 | NILOTINIB |
| 220006583 | 220002534 | 0 | null | Disease modification (D) | 2014-02-18 | 2015-07-04 | Nilotinib | N | N | 220030597 | NILOTINIB |
| 220006584 | 220011458 | 1.6 | 0 | Curative (C) | 2016-04-16 | 2016-04-20 | Nilotinib | N | N | 220030600 | NILOTINIB |
| 220006585 | 220011458 | null | null | Curative (C) | null | 2015-10-28 | AML Interim Guidelines FLA | null | null | 220030600 | NOT MATCHED |
| 220006586 | 220011458 | 1.74 | 0 | Curative (C) | 2015-10-21 | 2015-10-21 | Nilotinib | null | null | 220030600 | NILOTINIB |
| 220006587 | 220002535 | 1.72 | null | Curative (C) | 2015-07-24 | 2015-07-24 | Nilotinib | 2 | null | 220030610 | NILOTINIB |
| 220006588 | 220002535 | 0 | null | Curative (C) | 2013-07-19 | 2013-07-19 | Nilotinib | 2 | N | 220030610 | NILOTINIB |
| 220006589 | 220002535 | 0 | 0 | Palliative (P) | null | 2014-10-17 | Nilotinib | 02 | N | 220030610 | NILOTINIB |
| 220006592 | 220002537 | 1.81 | 93.2 | Disease modification (D) | 2015-03-27 | 2015-11-23 | Nilotinib | 2 | N | 220030622 | NILOTINIB |
| 220006593 | 220002537 | 1.66 | 79.2 | Curative (C) | 2016-01-13 | 2016-01-13 | AML 19 TRIAL | 01 | N | 220030622 | AML19 TRIAL |
| 220006594 | 220002537 | null | 8.4 | Curative (C) | 2016-12-16 | 2016-12-17 | AML Interim Guidelines FLA -Ida | N | N | 220030622 | NOT MATCHED |
| 220006595 | 220002537 | 1.56 | 60.2 | Curative (C) | 2014-09-08 | 2014-09-08 | AML 19 TRIAL | Y | null | 220030622 | AML19 TRIAL |
| 220006596 | 220002538 | 1.68 | 81.4 | Curative (C) | 2014-10-31 | 2014-10-31 | AML 19 TRIAL | Y | N | 220030628 | AML19 TRIAL |
| 220006597 | 220002538 | 0 | null | Disease modification (D) | 2016-09-28 | 2016-12-24 | Nilotinib | N | null | 220030628 | NILOTINIB |
| 220006598 | 220002539 | 1.74 | 53.8 | Curative (C) | 2014-08-06 | 2014-08-06 | AML 19 TRIAL | 01 | null | 220030630 | AML19 TRIAL |
| 220006599 | 220002539 | 1.72 | 94.1 | Curative (C) | 2014-08-06 | 2014-08-06 | FLAG + Idarubicin | null | N | 220030630 | FLAG + IDARUBICIN |
| 220006600 | 220002540 | 1.96 | null | null | 2017-10-20 | 2017-10-27 | FLAG + Idarubicin | null | null | 220030636 | FLAG + IDARUBICIN |
| 220006601 | 220002541 | 1.15 | 73 | Curative (C) | 2016-07-12 | 2016-10-15 | AML Interim Guidelines FLA | 2 | N | 220030638 | NOT MATCHED |
| 220006604 | 220016166 | 1.77 | 86.1 | Curative (C) | 2014-09-30 | 2014-10-05 | AML 19 TRIAL | Y | N | 220030641 | AML19 TRIAL |
| 220006605 | 220016166 | null | null | Disease modification (D) | 2013-01-28 | 2013-09-28 | Nilotinib | null | N | 220030641 | NILOTINIB |
| 220006606 | 220016166 | 0 | 0 | Disease modification (D) | null | 2016-03-26 | Nilotinib | 02 | N | 220030641 | NILOTINIB |
| 220006607 | 220021256 | 1.81 | 73 | Curative (C) | 2013-10-18 | 2013-10-18 | Nilotinib | 2 | Y | 220030648 | NILOTINIB |